Abstract
Risk of stratified therapies for antiphospholipid antibody syndrome (APS) in pregnancy: is tailored treatment ready for prime time?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1111/j.1538-7836.2005.01194.x
Publication Date: Feb 1, 2005 | |
License type: publisher-specific-oa |
Risk of stratified therapies for antiphospholipid antibody syndrome (APS) in pregnancy: is tailored treatment ready for prime time?
Join us for a 30 min session where you can share your feedback and ask us any queries you have